trending Market Intelligence /marketintelligence/en/news-insights/trending/ssnngjc3witjfg8grvv-iq2 content esgSubNav
In This List

OncoSil Medical closes institutional placement

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


OncoSil Medical closes institutional placement

OncoSil Medical Ltd. closed the first tranche of its previously announced non-underwritten institutional placement of 106.1 million shares.

The company issued 72.7 million shares at 12 Australian cents each in the first tranche, raising A$8.7 million.

OncoSil will issue 33.3 million shares at the same price under the second tranche, for proceeds of about A$4 million. The second tranche is subject to shareholder approval at a May 4 meeting.

Wilsons Corporate Finance Ltd. is managing the institutional placement.

Australia-based OncoSil is a late-stage medical device company that develops localized cancer treatments.